Government shutdowns lead to decreased predictability, causing delays in new submissions and manufacturing changes. Key risk ...

Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...

February 11 is the International Day of Women and Girls in Science (1). This day focuses on the gender gap in science, ...

HanchorBio and WuXi Biologics collaborate to develop fusion proteins using the Fc-Based Designer Biologics platform, ...

He helps companies lay the foundation for successful launches through data-backed strategies spanning indication assessment ...

Tariffs and significant US manufacturing investments complicate ROI calculations and increase operational costs, challenging ...

Mirum Pharmaceuticals acquires Bluejay Therapeutics, focusing on brelovitug for chronic hepatitis delta virus (HDV), a severe ...

Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

PharmTech is rebranding to strengthen its commitment to scientists, innovators, and executives in the pharmaceutical industry ...

WHO refuted US claims of failure and politicization, emphasizing its impartiality and historical contributions to global health. US WHO withdrawal triggers pharma regulatory and supply chain risks ...

Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV poses a higher risk of complications in adults, especially those with ...

Collaboration between development, quality, and purchasing departments is crucial for a secure supply chain, reducing risks ...